Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database
BackgroundStatins, as an important class of lipid-lowering drugs, play a key role in the prevention and treatment of cardiovascular diseases. However, with their widespread use in clinical practice, some adverse events have gradually emerged. In particular, the hepatotoxicity associated with statins...
Saved in:
Main Authors: | Bojing Wang, Shu Huang, Shiqi Li, Yaqi Deng, Ziyan Li, Yizhou Wang, Xiaomin Shi, Wei Zhang, Lei Shi, Xiaohong Wang, Xiaowei Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1502791/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins
by: Zhuangqi Shi, et al.
Published: (2025-01-01) -
Correspondence on 'Is ChatGPT an Accurate and Reliable Source of Information for Patients with Vaccine and Statin Hesitancy?'
by: Hinpetch DAUNGSUPAWONG, et al.
Published: (2024-06-01) -
Statins—Their Effect on Lipoprotein(a) Levels
by: Marcin Mateusz Granat
Published: (2025-01-01) -
Impact of statin use on major adverse cardiovascular events in patients with normal stress myocardial perfusion imaging and elevated coronary artery calcium score
by: Yi Hui To, et al.
Published: (2023-02-01) -
An Overview of the Impact of Statin Therapy on Cardiac Incident Risk
by: Urszula Świrk, et al.
Published: (2025-02-01)